- Home
- RELY vs AXNX Comparison
RELY vs AXNX Comparison
Compare RELY & AXNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RELY
- AXNX
- Stock Information
- Founded
- RELY 2011
- AXNX 2012
- Country
- RELY United States
- AXNX United States
- Employees
- RELY N/A
- AXNX N/A
- Industry
- RELY Computer Software: Prepackaged Software
- AXNX Medical/Dental Instruments
- Sector
- RELY Technology
- AXNX Health Care
- Exchange
- RELY Nasdaq
- AXNX Nasdaq
- Market Cap
- RELY 3.9B
- AXNX 3.6B
- IPO Year
- RELY 2021
- AXNX N/A
- Fundamental
- Price
- RELY $20.68
- AXNX N/A
- Analyst Decision
- RELY Buy
- AXNX Hold
- Analyst Count
- RELY 9
- AXNX 8
- Target Price
- RELY $22.75
- AXNX $71.00
- AVG Volume (30 Days)
- RELY 2.7M
- AXNX 571.3K
- Earning Date
- RELY 10-30-2024
- AXNX 11-07-2024
- Dividend Yield
- RELY N/A
- AXNX N/A
- EPS Growth
- RELY N/A
- AXNX N/A
- EPS
- RELY N/A
- AXNX N/A
- Revenue
- RELY $1,176,826,000.00
- AXNX $431,902,000.00
- Revenue This Year
- RELY $35.55
- AXNX $25.35
- Revenue Next Year
- RELY $24.14
- AXNX $19.92
- P/E Ratio
- RELY N/A
- AXNX N/A
- Revenue Growth
- RELY 35.18
- AXNX 26.08
- 52 Week Low
- RELY $11.60
- AXNX $55.09
- 52 Week High
- RELY $22.49
- AXNX $71.05
- Technical
- Relative Strength Index (RSI)
- RELY 79.24
- AXNX 1.26
- Support Level
- RELY $19.25
- AXNX $70.37
- Resistance Level
- RELY $20.80
- AXNX $71.05
- Average True Range (ATR)
- RELY 0.70
- AXNX 0.15
- MACD
- RELY 0.01
- AXNX -8.31
- Stochastic Oscillator
- RELY 89.65
- AXNX 0.00
About RELY Remitly Global Inc.
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. The company's revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
About AXNX Axonics Inc.
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.